Stockreport

BioCardia Inc (BCDA) Q4 2025 Earnings Call Highlights: Promising Clinical Results Amid ... [Yahoo! Finance]

BioCardia, Inc.  (BCDA) 
PDF Research and Development Expense: Increased by 13% to $5 million in 2025 from $4.4 million in 2024. Selling, General and Administrative Expenses: Decreased by 10% to [Read more]